Cargando…
DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers
Promoter CpG methylation of tumour suppressor genes (TSGs) is an epigenetic biomarker for TSG identification and molecular diagnosis. We screened genome wide for novel methylated genes through methylation subtraction of a genetic demethylation model of colon cancer (double knockout of DNMT1 and DNMT...
Autores principales: | Ying, J, Poon, F F, Yu, J, Geng, H, Wong, A H Y, Qiu, G-H, Goh, H K, Rha, S Y, Tian, L, Chan, A T C, Sung, J J Y, Tao, Q |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653732/ https://www.ncbi.nlm.nih.gov/pubmed/19156137 http://dx.doi.org/10.1038/sj.bjc.6604888 |
Ejemplares similares
-
Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomas
por: Wang, Zhaohui, et al.
Publicado: (2012) -
RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer
por: Endoh, M, et al.
Publicado: (2005) -
Evaluation of single CpG sites as proxies of CpG island methylation states at the genome scale
por: Barrera, Víctor, et al.
Publicado: (2012) -
DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma
por: Seng, T J, et al.
Publicado: (2008) -
Transcriptional silencing of the Dickkopfs-3 (Dkk-3) gene by CpG hypermethylation in acute lymphoblastic leukaemia
por: Roman-Gomez, J, et al.
Publicado: (2004)